Memorial Sloan Kettering Cancer Center
- COVID-19
- Myeloma
- Leukemia
- Lymphoma
- Hematologic Transplantation and Malignancies
- Breast
- Lung
- Gastrointestinal
- Genitourinary
- Gynecologic
- Skin
- Head and Neck
- Brain
- General Oncology
- Palliative Care
- Events
- MPN
Playback speed
10 seconds
Current and Future Personalized Systemic Targets in Esophagogastric Cancer: Anti-HER2, Anti-VEGF, TAS-102, and Claudin 18.2
By
Memorial Sloan Kettering Cancer Center
FEATURING
Geoffrey Ku
By
Memorial Sloan Kettering Cancer Center
FEATURING
Geoffrey Ku
280 views
September 24, 2019
Login to view comments.
Click here to Login
Gastrointestinal